Journal List > J Korean Ophthalmol Soc > v.51(6) > 1008836

Kim, Yang, and Jee: Stability of Four-Haptic Intraocular Lens in Combined Phacoemulsification and Vitrectomy

Abstract

Purpose

To evaluate the stability of intraocular lenses (IOLs) according to the haptic design in combined surgery (phacoemulsification, intraocular lens insertion, and vitrectomy) by comparing early IOP elevation and the accuracy of IOL power.

Methods

A retrospective study was conducted for 85 eyes of 85 patients who had undergone combined surgery. IOP elevation one week postoperatively and the difference between target refraction and postoperative refraction after two months were evaluated in all patients. All eyes were allocated to either a 2-haptic IOL group or a 4-haptic IOL group, and then each group was divided into three subgroups: gas-filled, silicone oil-filled, or balanced salt solution-filled.

Results

In the balanced salt solution-filled group, the early IOP increase was significantly less in the 4-haptic IOL group than it was in the 2-haptic IOL group (3.24 mmHg vs. 6.15 mm Hg, p=0.025).
The myopic shifts of the 2-haptic IOL group were significantly greater than those of the 4-haptic IOL group for all of the sub-groups (gas subgroup -0.71D vs. -0.31D, p=0.045; balanced salt solution subgroup -0.66D vs. -0.16D, p=0.018).

Conclusions

In combined surgery, 4-haptic IOL implantation showed significantly less early IOP elevation and less myopic shift than those of 2-haptic IOL implantation.

References

1. Koening SB, Han DP, Mieler WF, et al. Combined phacoemulsification and pars plana vitrectomy. Arch Ophthalmol. 1990; 108:362–4.
crossref
2. Benson WE, Brown GC, Tasman W, et al. Extracapsular cataract extraction, posterior chamber lens insertion, and pars plana vitrectomy in one operation. Ophthalmology. 1990; 97:918–21.
crossref
3. Smiddy WE, Stark WJ, Michels RG, et al. Cataract extraction after vitrectomy. Ophthalmology. 1987; 94:483–7.
crossref
4. Hutton WL, Pesicka GA, Fuller DG. Cataract extraction in the diabetic eye after vitrectomy. Am J Ophthalmol. 1987; 104:1–4.
crossref
5. Lahey JM, Francis RR, Kearney JJ. Combining phacoemulsification with pars plana vitrectomy in patients with proliferative diabetic retinopathy: a series of 223 cases. Ophthalmology. 2003; 110:1335–9.
6. Koenig SB, Mieler WF, Han DP, et al. Combined phacoemulsification, pars plana vitrectomy, and posterior chamber intraocular lens insertion. Arch Ophthalmol. 1992; 110:1101–4.
crossref
7. Hurley C, Barry P. Combined endocapsular phacoemulsification, pars plana vitrectomy, and intraocular lens implantation. J Cataract Refract Surg. 1996; 22:462–6.
crossref
8. Blankenship GW, Flynn HW, Kokame GT. Posterior chamber intraocular lens insertion during pars plana lensectomy and vitrectomy for complications of proliferative diabetic retinopathy. Am J Ophthalmol. 1989; 108:1–5.
crossref
9. Hwang JJ, Kim YY, Huh K. Risk factors of intraocular pressure evaluation after pars plana vitrectomy. J Korean Ophthalmol Soc. 2000; 41:945–50.
10. Suzuki Y, Sakuraba T, Mizutani H, et al. Postoperative refractive error after simultaneous vitrectomy and cataract surgery. Ophthamic Surg Lasers. 2000; 31:271–5.
crossref
11. Jeoung JW, Chung H, Yu HG. Factors influencing refractive outcomes after combined phacoemulsification and pars plana vitrectomy. J Cataract Refract Surg. 2007; 33:108–14.
crossref
12. Sun HJ, Choi KS. Improving intraocular lens power prediction in combined phacoemulsification and vitrectomy in eyes with macular oedema. Acta Ophthalmol. 2009. Nov; Epub.
crossref
13. Ehmann D, García R. Investigating a possible cause of myopic shift after combined cataract extraction, intraocular lens implantation, and vitrectomy for treatment of macular hole. Can J Ophthalmol. 2009; 44:594–7.
14. Han DP, Lewis H, Lambrow FH, et al. Mechanisms of intraocular pressure elevation after pars plana vitrectomy. Ophthalmology. 1989; 96:1357–62.
15. Chang S, Coleman DJ, Lincoff H, et al. Perfluoropropane gas in the management of proliferative vitreoretinopathy. Am J Ophthalmol. 1984; 98:180–8.
crossref
16. Lincoff H, Coleman J, Kreissig I, et al. The perfluorocarbon gases in the treatment of retinal detachment. Ophthalmology. 1983; 90:546–51.
crossref
17. Chang S, Lincoff H, Coleman DJ, et al. Perfluorocarbon gases in vitreous surgery. Ophthalmology. 1985; 92:651–6.
crossref
18. Lincoff H, Kreissif I, Brodie S, et al. Expanding gas bubbles for the repair of tears in the posterior pole. Graefes Arch Klin Exp Ophthalmol. 1982; 219:193–7.
crossref
19. Peters MA, Abrams GW, Hamilton LH, et al. The nonexpansile, equilibrated concentration of perfluoropropane gas in the eye. Am J Ophthalmol. 1985; 100:831–9.
crossref
20. Ni C, Wang WJ, Albert DM, et al. Intravitreous silicone injection. Histopathologic findings in a human eye after 12 years. Arch Ophthalmol. 1983; 101:1399–401.
21. Lee SS, Kim HJ. Clinical Results of Acrysof IOLs and Acryl-C160 IOLs in Complicated Cataracts. J Korean Ophthalmol Soc. 2002; 43:35–41.
22. Lee JY, Joo KM, Kim SH. Late Opacification of Hydrophilic Acrylic Intraocular Lenses. J Korean Ophthalmol Soc. 2002; 43:2419–29.
23. Kim SW, Kim HS, Oh JR, et al. Risk Factors of Posterior Synechia of the Iris after Performing Vitrectomy and Cataract Surgery Simultaneously. J Korean Ophthalmol Soc. 2005; 46:1128–37.

Table 1.
Characteristics of two Intraocular lenses (IOL) in the study
2-haptic IOL (n=46) 4-haptic IOL (n=39)
Model Acrysof IQ, Alcon®, U.S.A. MI60, Bausch & Lomb®, Germany
Material hydrophobic acrylic hydrophilic acrylic
Optic diameter (mm) 6.0 5.6-6.2
Overall diameter (mm) 13.0 10.5-11.0
Haptic angle 0 degree 10 degree
A-constant 118.7 118.4
Table 2.
Patient demographics
2-haptic IOL group 4-haptic IOL group
Age (years) 63.40±10.25 66.15±6.17
Sex
 Male (n) 22 15
 Female (n) 24 24
Systemic disease
 Diabetes (n) 37 29
 Hypertension (n) 29 26
Cause (%)
 * PDR vitreous hemorrhage 20 (43.5) 16 (41.0)
 PDR c TRD 8 (17.4) 9 (23.1)
  BRVO vitreous hemorrhage 7 (15.2) 5 (12.8)
 Retinal tear c § RD 7 (15.2) 4 (12.3)
 Macular hole 2 (4.3) 3 (7.7)
 Macular hemorrhage 2 (4.3) 2 (5.1)
Total 46 (100) 39 (100)

* PDR=proliferative diabetic retinopathy;

TRD=tractional retinal detachment;

BRVO=branched retinal vein occlusion;

§ RD= retinal detachment.

Table 3.
Comparison of postoperative IOP increase and refractive errors in the 2-haptic and 4-haptic IOL group
2-haptic IOL (n=46) 4-haptic IOL (n=39) § p-value
Preoperative
 Axial length (mm) 23.10±0.98 23.45±1.14 0.203
 Anterior chamber depth (mm) 3.06±0.32 3.09±0.43 0.368
 Intraocular pressure (mm Hg) 11.47±2.94 12.55±2.66 0.604
Material of tamponade
 C3F8 gas tamponade (n) 17 12
  * IOP increase (mm Hg) 9.17±10.25 9.75±14.82 0.512
   Myopic shift (Diopter) -0.71±1.09 -0.31±0.84 0.045
 Silicone oil tamponade 10 13
  * IOP increase (mm Hg) 11.22±9.74 9.34±10.25 0.429
  With removal (n) 4 5
   Myopic shift (Diopter) -0.69±0.81 -0.87±0.62 0.102
 Balanced salt solution (n) 19 14
  * IOP increase (mm Hg) 6.15±8.13 3.24±4.12 0.025
   Myopic shift (Diopter) -0.66±1.02 -0.16±0.70 0.018

* Difference between maximum value of postoperative IOP within postoperative 1-week and preoperative IOP;

Difference between post-vitrectomy 2 months spherical equivalent and preoperative target spherical equivalent;

Difference between post-silicone oil removal 2 months spherical equivalent and pre-silicone oil removal target spherical equivalent;

§ p-value was determined by Mann-Whitney U-test.

TOOLS
Similar articles